Correlation Between Anixa Biosciences and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and Cue Biopharma, you can compare the effects of market volatilities on Anixa Biosciences and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Cue Biopharma.
Diversification Opportunities for Anixa Biosciences and Cue Biopharma
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Anixa and Cue is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Cue Biopharma go up and down completely randomly.
Pair Corralation between Anixa Biosciences and Cue Biopharma
Given the investment horizon of 90 days Anixa Biosciences is expected to generate 0.5 times more return on investment than Cue Biopharma. However, Anixa Biosciences is 1.99 times less risky than Cue Biopharma. It trades about -0.2 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.26 per unit of risk. If you would invest 397.00 in Anixa Biosciences on August 29, 2024 and sell it today you would lose (65.00) from holding Anixa Biosciences or give up 16.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anixa Biosciences vs. Cue Biopharma
Performance |
| Timeline |
| Anixa Biosciences |
| Cue Biopharma |
Anixa Biosciences and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anixa Biosciences and Cue Biopharma
The main advantage of trading using opposite Anixa Biosciences and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Anixa Biosciences vs. Eliem Therapeutics | Anixa Biosciences vs. Scpharmaceuticals | Anixa Biosciences vs. Milestone Pharmaceuticals | Anixa Biosciences vs. Seres Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |